Predictors of euthyreosis in hyperthyroid patients treated with radioiodine (131)I(−): a retrospective study

BACKGROUND: Radioiodine (RAI) treatment for hyperthyroidism is a very common modality, chosen by physicians worldwide. The outcome of the therapy, however, is not always predictable. While rendering a patient hypo- or euthyroid is meant as a therapeutic success, the latter does not require lifelong...

Descripción completa

Detalles Bibliográficos
Autores principales: Stachura, Albert, Gryn, Tomasz, Kałuża, Bernadetta, Budlewski, Tadeusz, Franek, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268615/
https://www.ncbi.nlm.nih.gov/pubmed/32487052
http://dx.doi.org/10.1186/s12902-020-00551-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268615/
https://www.ncbi.nlm.nih.gov/pubmed/32487052
http://dx.doi.org/10.1186/s12902-020-00551-2

Ejemplares similares